The aim of the study was to evaluate the efficacy of orally administered bovine lactoferrin (bLF) on Urinary Tract Infections in neonates and infants. Fifty-five patients with urinary tract infection were randomized to receive either bLF (n = 27) or an identical placebo (n = 28) for 4 weeks. The patients were assessed clinically and laboratory.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Monitoring of parameters of inflammation.
Timeframe: at baseline, after 5 days of treatment
Influence of lactoferrin on Interleukin-6 and Interleukin-8.
Timeframe: at baseline, after 5 days of treatment
Effect of lactoferrin on white blood cells.
Timeframe: at baseline, after 5 days of treatment
Effect of lactoferrin on urinary inflammatory markers.
Timeframe: at baseline, after 5 days of treatment